Neuronetics, Inc. Release: New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients With Depression using NeuroStar TMS Therapy System
5/22/2013 9:41:13 AM
More...
|
Neuronetics, Inc. Release: NeuroStar TMS Therapy, a Non-Drug Depression Treatment, Demonstrates Statistically Significant Benefits on Patient-Reported Pain Outcomes
3/20/2013 8:51:47 AM
More...
|
Neuronetics, Inc., Honored with Prestigious Industry Award for the NeuroStar TMS Therapy® System at Phoenix 2012 Conference
10/18/2012 1:00:07 PM
More...
|
Neuronetics, Inc. Receives CE Mark Approval for NeuroStar TMS Therapy
6/4/2012 8:11:07 AM
More...
|
Neuronetics, Inc. Release: Non-Drug Depression Treatment Rapidly and Significantly Improves Disease Symptoms and Quality of Life
5/9/2012 9:59:40 AM
More...
|
New Trial Data Confirm Clinical Effectiveness and Good Adherence Rates With Neuronetics, Inc.'s NeuroStar TMS Therapy in Patients With Major Depressive Disorder Treated in a Real World Practice Setting
5/16/2011 7:44:53 AM
More...
|
Neuronetics, Inc. Raises $30 Million in Series E Financing
5/16/2011 7:33:58 AM
More...
|
Neuronetics, Inc. Receives TiE50 Award for Technology Entrepreneurship
5/9/2011 9:01:22 AM
More...
|
Neuronetics, Inc. Release: New Data Show No Negative Long-Term Effect in Cognitive Function in Patients With Major Depressive Disorder Treated With NeuroStar TMS Therapy(R)
4/14/2011 1:21:26 PM
More...
|
Neuronetics, Inc. Appoints Vice President of Health Policy and Government Relations
3/2/2011 8:26:34 AM
More...
|
|